Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
Palabras clave :
Antiseizure medication
Cannabidiol
Epilepsy
Focal seizures
Medication-resistant seizures
Tuberous sclerosis complex
Fecha de publicación :
2022
Nota:
Creative Commons Attribution-NonCommercial License
Cita:
Wu JY, Cock HR, Devinsky O, Joshi C, Miller I, Roberts CM, et al. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Epilepsia. 2022;63:1189–1199.
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.